Source: University of South Florida
Date: July 19, 2010
Summary:
A combination of nutrients called NT-020 promoted adult neural stem cell proliferation in aged rats and boosted their memory performance, reported University of South Florida researchers studying natural therapeutic approaches to promoting the health of neurons in the aging brain.
Researchers from the USF Department of Neurosurgery and Brain Repair tested two groups of aged laboratory rats; one group received NT-020 and another, the control group, did not. In the NT-020 group, the process by which neurons are generated -- called neurogenesis -- increased. The study was published in the current issue of Rejuvenation Research (Vol. 13 No. 5, June, 2010). The NT-020 formula was patented by USF and licensed to Natura Therapeutics, Inc.
Showing posts with label cancer nerve cells. Show all posts
Showing posts with label cancer nerve cells. Show all posts
Monday, July 19, 2010
Tuesday, June 08, 2010
TAU research is inventing a tool to control the risk of "runaway" stem cells
Source: American Friends of Tel Aviv University
Date: June 8, 2010
Summary:
Stem cell research holds promise for improving the quality of human life -- especially embryonic stem cells, which can potentially develop into any tissue in the human body. Basic scientific problems still remain unresolved -- but Tel Aviv University researchers are leading the way to inventive solutions. The implications of this research can provide the basis for a new kind of research tool, one that biologists around the world could use to define and grow the specific kinds of neural stem cells they require.
Date: June 8, 2010
Summary:
Stem cell research holds promise for improving the quality of human life -- especially embryonic stem cells, which can potentially develop into any tissue in the human body. Basic scientific problems still remain unresolved -- but Tel Aviv University researchers are leading the way to inventive solutions. The implications of this research can provide the basis for a new kind of research tool, one that biologists around the world could use to define and grow the specific kinds of neural stem cells they require.
Wednesday, June 02, 2010
City of Hope receives FDA approval for first human neural stem cell clinical trial to treat brain tumors
Source: City of Hope National Medical Center
Date: June 2, 2010
Summary:
DUARTE, Calif., — City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor.
Date: June 2, 2010
Summary:
DUARTE, Calif., — City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor.
Subscribe to:
Posts (Atom)